Leniolisib
| CAS No. | 1354690-24-6 | Cat. No. | BCP30455 |
| Name | Leniolisib | ||
| Synonyms | CDZ-173; CDZ 173; CDZ173; | ||
| Formula | C21H25F3N6O2 | M. Wt | 450.46 |
| Description | Leniolisib (CDZ173) is a potent and selective PI3Kδ inhibitor currently in phase II/III clinical trials for the treatment of immunodeficiency disorders. | ||
| Pathways | PI3K/Akt/mTOR | ||
| Targets | PI3K | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.